Article
Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application
1 Sept 2016
Abstract excerpt
From 2006 to 2011, Roslin Cells Ltd derived 17 human embryonic stem cells (hESC) while developing (RCM1, RC-2 to -8, -10) and implementing (RC-9, -11 to -17) quality assured standards of operation in a facility operating in compliance with European Union (EU) directives and United Kingdom (UK) licensure for procurement, processing and storage of human cells as source material for clinical application, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
